Skip to content
Home » News » OASAS rejects two of New York Opioid Settlement Fund Advisory Board’s suggestions

OASAS rejects two of New York Opioid Settlement Fund Advisory Board’s suggestions

Last week the New York Opioid Settlement Fund Advisory Board held a meeting after OASAS rejected suggestions they made for funding harm reduction when it comes to opioids.

Opioid settlement funds are supposed to go toward harm reduction, but how to spend that money is still up in the air.

DiSanto Propane (Billboard)

OASAS recently created their own harm reduction unit, but they refused to use funding for overdose prevention centers. These centers are considered a place where harm reduction can take place.

OASAS may have also chosen to not fund treatment for harm reduction provided by the New York State Department of Health.

Categories: New York StateNews

Top